In conclusion, we have carried out research from molecular, cellular, animal models, and clinical specimens to elucidate the molecular mechanism of the interaction between CIB1 and CHIP in inducing migration and invasion of lung adenocarcinoma cells, and to provide experimental evidence for the treatment of new targets for lung adenocarcinoma. This evidence concerns the gene CIB1 and lung adenocarcinoma.